业界动态国内医卫资讯

首创药物对帕金森病运动波动安全有效

Medscape News · 2026-11-11 15:27

摘要

新的3期数据显示,与安慰剂相比,新型GPR6抑制剂solengepras与帕金森病患者每日OFF时间的更大改善相关。Medscape Medical News

English
First-in-Class Med Safe, Effective for PD Motor Fluctuations

The novel GPR6 inhibitor solengepras is linked to greater improvement in daily OFF time compared to placebo in patients with Parkinson’s disease, new phase 3 data show. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界